View the full site

The heart of Triton fund IV company Bormioli Pharma can be summed up in four words: “Small part, Big Impact”. Since becoming a stand-alone company in November 2017, the company pinpointed this very concept that animates its behaviour every day.

Bormioli Pharma, a leading pharma primary packaging manufacturer, produces "small things"  – however, these small things have a “big impact” on people’s lives. This motto is also more than just a description of what the company does, it is an important part of the company’s culture. It means striving for perfection and continuous innovation, aware that every detail matters.  

“Small part, Big Impact” can also be seen in Bormioli Pharma’s new corporate design and is also reflected in the company’s five-year strategic plan.

 

 

BORMIOLI PHARMA

We aim to build better companies, however, our ambition is not possible without our portfolio company employees. Our Human Capital Practice supports portfolio companies and Triton investment teams in fostering teams, building talent bench strengths and optimizing organizational practices.

Human capital plays an important role throughout the portfolio lifecycle. It begins with assessing and onboarding executives and continues with developing leadership, implementing initiatives and aligning the organizational culture. The Triton Human Capital Practice assists at every stage throughout this process.

 

 

HUMAN CAPITAL
70+
investments made since 1999
260+
add-on acquisitions supported
37
companies in portfolio
€14bn
total capital commitment of 8 sponsored closed funds
  • 70+
    investments made since 1999
  • 260+
    add-on acquisitions supported
  • 37
    companies in portfolio
  • €14bn
    total capital commitment of 8 sponsored closed funds
At a glance

We know the sectors in which we are involved really well - and like to get to know potential portfolio companies years before we invest.

About us